Dreesen, Erwin : rechercher sur Z-Library

Année:

2018

Langue:

english

Fichier:

PDF, 2.66 MB

english, 2018

Mo1847 - Reactive Dose Escalation of Infliximab in Patients with Crohn's Disease in Tailorix Leads to Improved Outcomes

Dreesen, Erwin, Laharie, David, Lambrecht, Guy, Bossuyt, Peter, Buisson, Anthony, Filippi, Jerome, Van Hootegem, Philippe, D'Haens, Geert R., Vermeire, Severine, Gils, Ann

Journal:

Vermeire, Severine, Dreesen, Erwin, Papamichael, Konstantinos, Dubinsky, Marla C.

Année:

2018

Langue:

english

Fichier:

PDF, 1.14 MB

english, 2018

How, When, and For Whom Should We Perform Therapeutic Drug Monitoring?

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 350 KB

english, 2019

Variability in Golimumab Exposure: A ‘Real-Life’ Observational Study in Active Ulcerative Colitis

Detrez, Iris, Dreesen, Erwin, Van Stappen, Thomas, de Vries, Annick, Brouwers, Els, Van Assche, Gert, Vermeire, Séverine, Ferrante, Marc, Gils, Ann

Journal:

Année:

2016

Langue:

english

Fichier:

PDF, 902 KB

english, 2016

Sa1943 Variability in Vedolizumab Exposure Between Patients With Inflammatory Bowel Disease

Gils, Ann, Dreesen, Erwin, Peeters, Miet, Brouwers, Els, Ferrante, Marc, Van Assche, Gert, Vermeire, Severine

Journal:

Gils, Ann, Van Stappen, Thomas, Dreesen, Erwin, Storme, Ruth, Vermeire, Séverine, Declerck, Paul J.

Année:

2016

Langue:

english

Fichier:

PDF, 625 KB

english, 2016

Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples

Journal:

American Journal of Gastroenterology

Année:

2016

Langue:

english

Fichier:

PDF, 223 KB

english, 2016

A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease

Billiet, Thomas, Dreesen, Erwin, Cleynen, Isabelle, Wollants, Willem-Jan, Ferrante, Marc, Van Assche, Gert, Gils, Ann, Vermeire, Severine

Journal:

Année:

2016

Langue:

english

Fichier:

PDF, 280 KB

english, 2016

Blocking α4β7 Integrin Through Vedolizumab: Necessary but not Sufficient?

Journal:

Passot, Christophe, Pouw, Mieke, Mulleman, Denis, Bejan-Angoulvant, Theodora, Paintaud, Gilles, Dreesen, Erwin, Ternant, David

Année:

2017

Langue:

english

Fichier:

PDF, 124 KB

english, 2017

Therapeutic drug monitoring of biopharmaceuticals may benefit pharmacokinetic and pharmacokinetic–pharmacodynamic modeling

Journal:

Murias, Sara, Magallares, Lorena, Albizuri, Fatima, Pascual-Salcedo, Maria Dora, Dreesen, Erwin, Mulleman, Denis

Année:

2017

Langue:

english

Fichier:

PDF, 719 KB

english, 2017

Current practices for pediatric therapeutic drug monitoring of biopharmaceuticals

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 523 KB

english, 2017

Antibodies Towards Vedolizumab Appear from Week 2 Onwards and Disappear upon Treatment

Bian, Sumin, Tang, Ho Tsun, Peeters, Miet, Compernolle, Griet, Dreesen, Erwin, Van Assche, Gert A., Ferrante, Marc, Vermeire, Severine, Gils, Ann

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 1.05 MB

english, 2017

Anti-Infliximab Antibody Concentrations Guide Therapeutic Decision-Making in Patients with Crohn's Disease Losing Clinical Response

Dreesen, Erwin, Van Stappen, Thomas, Ballet, Vera, Tops, Sophie, Compernolle, Griet, Van Assche, Gert A., Ferrante, Marc, Vermeire, Severine, Gils, Ann

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 952 KB

english, 2017

Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time

Bian, Sumin, Dreesen, Erwin, Tang, Ho Tsun, Compernolle, Griet, Peeters, Miet, Van Assche, Gert, Ferrante, Marc, Vermeire, Séverine, Gils, Ann

Journal:

Dreesen, Erwin, D'Haens, Geert R., Baert, Filip J., Pariente, Benjamin, Bouhnik, Yoram, Van Der Woude, Christien Janneke, Moreau, Jacques, Laharie, David, Vermeire, Severine, Gils, Ann

Année:

2017

Langue:

english

Fichier:

PDF, 352 KB

english, 2017

Mo1841 - Infliximab Exposure Predicts Superior Endoscopic Outcomes in Patients with Active Crohn's Disease: Pharmacokineticpharmacodynamic Analysis of Tailorix

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 434 KB

english, 2018

Mo1846 - Adaptive Dosing During Infliximab Induction Therapy can Improve Mucosal Healing Rates in Patients with Ulcerative Colitis

Dreesen, Erwin, Faelens, Ruben, Van Assche, Gert A., Ferrante, Marc, Vermeire, Severine, Gils, Ann, Bouillon, Thomas

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 558 KB

english, 2018

Tu1867 - Clinical use of Infliximab Trough Levels During Maintenance in Pediatric Patients with Inflammatory Bowel Disease

van Hoeve, Karen, Hoffman, Ilse, Dreesen, Erwin, Ferrante, Marc, Ann, Gils, Vermeire, Severine

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 583 KB

english, 2018

Tu1868 - Infliximab Trough Levels after Induction Therapy: A Predictive Factor for Outcome in Pediatric Patients with Inflammatory Bowel Disease

van Hoeve, Karen, Hoffman, Ilse, Dreesen, Erwin, Ferrante, Marc, Ann, Gils, Vermeire, Severine

Journal:

Cochrane database of systematic reviews

Année:

2018

Langue:

english

Fichier:

PDF, 714 KB

english, 2018

Effectiveness and safety of switching IBD patients from the originator to the biosimilar infliximab

Strik, Anne S, Dreesen, Erwin, Samaan, Mark, Gecse, Krisztina, Matheeuwsen, Mijntje, Berends, Sophie, D'Haens, Geert

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 177 KB

english, 2018

Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases

Dreesen, Erwin, Bossuyt, Peter, Mulleman, Denis, Gils, Ann, Pascual-Salcedo, Dora

Journal:

Clinical Pharmacology Advances and Applications

Année:

2017

Langue:

english

Fichier:

PDF, 606 KB

english, 2017

Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease

van Hoeve, Karen, Dreesen, Erwin, Hoffman, Ilse, Van Assche, Gert, Ferrante, Marc, Gils, Ann, Vermeire, Séverine

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 313 KB

english, 2018

Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it! Authors’ reply

Alimentary Pharmacology & Therapeutics

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 292 KB

english, 2018

Ustekinumab exposure-outcome analysis in Crohn’s disease only in part explains limited endoscopic remission rates

Verstockt, Bram, Dreesen, Erwin, Noman, Maja, Outtier, An, Van den Berghe, Nathalie, Aerden, Isolde, Compernolle, Griet, Van Assche, Gert, Gils, Ann, Vermeire, Séverine, Ferrante, Marc

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 950 KB

english, 2019

879 – Switching from Infliximab Originator to a Biosimilar Does Not Affect Pharmacokinetics, Immunogenicity and Efficacy in Pediatric Patients with Inflammatory Bowel Disease

van Hoeve, Karen, Dreesen, Erwin, Hoffman, Ilse, Ferrante, Marc, Ann, Gils, Vermeire, Severine

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 177 KB

english, 2019

A Population Pharmacokinetic and Exposure–Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis

Dreesen, Erwin, Kantasiripitak, Wannee, Detrez, Iris, Stefanović, Sebastian, Vermeire, Séverine, Ferrante, Marc, Bouillon, Thomas, Drobne, David, Gils, Ann

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 731 KB

english, 2019

A Population Pharmacokinetic and Exposure–Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis

Dreesen, Erwin, Kantasiripitak, Wannee, Detrez, Iris, Stefanović, Sebastian, Vermeire, Séverine, Ferrante, Marc, Bouillon, Thomas, Drobne, David, Gils, Ann

Journal:

Année:

2019

Fichier:

PDF, 731 KB

2019

Influence of drug exposure on vedolizumab-induced endoscopic remission in anti-TNF naïve and anti-TNF exposed IBD patients

Verstockt, Bram, Mertens, Evelien, Dreesen,, Erwin, Outtier, An, Noman, Maja, Tops, Sophie, Schops, Ganel, Van Assche, Gert, Vermeire, Séverine, Gils, Ann, Ferrante, Marc

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 1.05 MB

english, 2019

Reply

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 61 KB

english, 2019

Tu1821 – Pharmacokinetic and Pharmacodynamic Evaluation of Radiological Healing in Crohn's Disease Patients Treated with Infliximab: A Tailorix Mre Substudy

Bossuyt, Peter, Dreesen, Erwin, Rimola, Jordi, De Vuysere, Sofie, De Bruecker, Yves, Vanslembrouck, Ragna, Laurent, valerie, Zappa, Magaly, Savoye-Collet, Celine, Gils, Ann, Vermeire, Severine, Peyrin

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 253 KB

english, 2019

Reply

Journal:

Année:

2019

Fichier:

PDF, 61 KB

2019

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease

Dreesen, Erwin, Baert, Filip, Laharie, David, Bossuyt, Peter, Bouhnik, Yoram, Buisson, Anthony, Lambrecht, Guy, Louis, Edouard, Oldenburg, Bas, Pariente, Benjamin, Pierik, Marieke, van der Woude, C. J

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 1.22 MB

english, 2019

Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease

van Hoeve, Karen, Dreesen, Erwin, Hoffman, Ilse, Van Assche, Gert, Ferrante, Marc, Gils, Ann, Vermeire, Séverine

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 315 KB

english, 2019

Efficacy, Pharmacokinetics, and Immunogenicity is Not Affected by Switching From Infliximab Originator to a Biosimilar in Pediatric Patients With Inflammatory Bowel Disease

van Hoeve, Karen, Dreesen, Erwin, Hoffman, Ilse, Van Assche, Gert, Ferrante, Marc, Gils, Ann, Vermeire, Séverine

Journal:

Année:

2019

Fichier:

PDF, 315 KB

2019

Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory Diseases

Journal:

Année:

2019

Fichier:

PDF, 177 KB

2019

Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohnâs Disease Likely to Achieve Endoscopic and Biochemical Remission

HanÅ¾el, Jurij, Zdovc, Jurij, Kurent, Tina, Sever, Nejc, Javornik, Katarina, Tuta, Katja, KoÅ¾elj, Matic, Smrekar, NataÅ¡a, Novak, Gregor, Å tabuc, Borut, Dreesen, Erwin, Thomas, Debby, Vovk, TomaÅ¾,

Journal:

Année:

2020

Fichier:

PDF, 3.05 MB

2020

Response to Letter to the Editor

Journal:

British Journal of Clinical Pharmacology

Année:

2020

Langue:

english

Fichier:

PDF, 220 KB

english, 2020

Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients with Crohn's Disease

Journal:

Année:

2020

Fichier:

PDF, 1.53 MB

2020

Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?

Kantasiripitak, Wannee, Van Daele, Ruth, Gijsen, Matthias, Ferrante, Marc, Spriet, Isabel, Dreesen, Erwin

Journal:

Frontiers in Pharmacology

Année:

2020

Fichier:

PDF, 1.71 MB

2020

Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review.

Kim, Hannah Yejin, MÃ¤rtson, Anne-Grete, Dreesen, Erwin, Spriet, Isabel, Wicha, Sebastian G., McLachlan, Andrew J., Alffenaar, Jan-Willem

Journal:

Frontiers in Pharmacology

Année:

2020

Fichier:

PDF, 1.55 MB

2020

Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohnâs Disease

Bossuyt, Peter, Dreesen, Erwin, Rimola, Jordi, Devuysere, Sofie, De Bruecker, Yves, Vanslembrouck, Ragna, Laurent, ValÃ©rie, Zappa, Magaly, Savoye-Collet, Celine, Pariente, Benjamin, Filippi, JÃ©rÃ´me

Journal:

van Hoeve, Karen, Dreesen, Erwin, Hoffman, Ilse, Ferrante, Marc, Vermeire, Severine

Année:

2020

Fichier:

PDF, 789 KB

2020

Mo1896 INFLIXIMAB SERUM LEVELS DURING INDUCTION PREDICT LONG-TERM ENDOSCOPIC REMISSION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE.

Journal: